{"gene":"GP1BA","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2003,"finding":"Crystal structure of the GPIbα–thrombin complex at 2.6 Å resolution reveals that GPIbα simultaneously contacts exosite I of one thrombin molecule and exosite II of a second thrombin molecule, providing a scaffold that could drive tight platelet adhesion.","method":"X-ray crystallography (2.6 Å resolution)","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure with direct identification of two distinct binding interfaces; foundational structural paper replicated and refined by subsequent studies","pmids":["12855811"],"is_preprint":false},{"year":2013,"finding":"GPIbα binds exclusively to thrombin's anion-binding exosite II (not exosite I), serving to recruit thrombin to the platelet surface while leaving exosite I free for PAR-1 recognition; demonstrated by mutational analysis, binding studies, X-ray crystallography, and NMR.","method":"Mutational analysis, binding studies, X-ray crystallography, NMR spectroscopy","journal":"Journal of Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (mutagenesis, crystallography, NMR) in a single rigorous study, with clear functional implication for PAR-1 activation","pmids":["24316004"],"is_preprint":false},{"year":2009,"finding":"NMR, AUC, and hydrogen-deuterium exchange studies show that GPIbα residues D274–E285 interact with thrombin's anion-binding exosite II in an extended conformation with 1:1 stoichiometry, and binding causes long-range conformational effects on thrombin.","method":"1D/2D NMR, analytical ultracentrifugation, hydrogen-deuterium exchange coupled with MALDI-TOF MS","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods in a single study defining the binding interface at residue resolution","pmids":["19591434"],"is_preprint":false},{"year":2004,"finding":"ADAM17 (TACE) is the key metalloproteinase mediating ectodomain shedding of GPIbα in platelets; TACE-deficient chimeric mice show ~90% reduction in soluble glycocalicin in plasma, increased surface GPIbα, and improved post-transfusion recovery and hemostatic function of damaged platelets.","method":"Chimeric mouse model with inactive TACE (TACEΔZn/ΔZn), TACE inhibitors (TAP1, TMI-1), in vivo and in vitro shedding assays","journal":"Circulation Research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function model combined with pharmacological inhibition, replicated across mouse and human platelets with multiple functional readouts","pmids":["15345652"],"is_preprint":false},{"year":2006,"finding":"GPIbα is absolutely required for platelet recruitment to exposed subendothelium and to growing thrombi under arterial flow conditions, independent of VWF binding; transgenic mice expressing GPIbα with the extracellular domain replaced by IL-4Rα showed virtually absent platelet adhesion and completely inhibited arterial thrombus formation.","method":"Transgenic mouse model (IL4Rα/GPIbα-tg), intravital microscopy of mesenteric arterioles, adoptive transfer experiments","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — well-controlled genetic model with direct in vivo intravital imaging and adoptive transfer experiments demonstrating GPIbα-specific mechanism","pmids":["17075060"],"is_preprint":false},{"year":2000,"finding":"The cytoplasmic domain of GPIbα (residues 570–590) is required for binding 14-3-3ζ; deletion of Trp570–Ser590 eliminates 14-3-3ζ binding. PKA-dependent phosphorylation of GPIbβ enhances 14-3-3ζ binding to the GPIb/IX/V complex. Under shear stress-induced platelet aggregation, 14-3-3ζ dissociates from GPIbα.","method":"Truncation/deletion mutagenesis, GST-pulldown, co-immunoprecipitation in CHO cells and human platelets, shear stress assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal pulldown and co-IP with structure-function mutagenesis, validated in both heterologous cells and native platelets","pmids":["10627461"],"is_preprint":false},{"year":2010,"finding":"The GPIbα–filamin A interaction is essential for maintaining membrane skeletal stability under high shear stress; disrupting this interaction (Phe568Ala/Trp570Ala mutations in human GPIbα) leads to unstable membrane tethers, defective platelet adhesion, and membrane disintegration at pathological shear rates (5,000–40,000 s⁻¹), without altering intrinsic ligand-binding function or integrin αIIbβ3-dependent spreading.","method":"Transgenic mouse model expressing filamin-binding-defective hGPIbα(FW), high-shear flow assays, intravital microscopy","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — targeted mutagenesis in transgenic mouse model with multiple functional readouts under defined shear conditions","pmids":["21156842"],"is_preprint":false},{"year":2011,"finding":"GPIbα regulates platelet size by controlling the subcellular localization of filamin A; coordinated expression of GPIbα and filamin is required for efficient trafficking of either protein to the cell surface, and their ratio determines normal proplatelet/platelet size.","method":"Embryonic stem cell differentiation into platelets, filamin knockdown, GPIbα overexpression, HEK293T trafficking assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple complementary cell models (ESC-derived platelets, HEK293T), genetic manipulation of both proteins, mechanistic link to trafficking demonstrated","pmids":["22174152"],"is_preprint":false},{"year":2011,"finding":"Desialylation of GPIbα by platelet sialidases (Neu1, Neu3) after refrigeration targets it for ADAM17-mediated ectodomain shedding; desialylation alone (without metalloproteinase-mediated shedding) is sufficient to cause rapid clearance of platelets from circulation.","method":"Sialidase inhibitor studies, Adam17ΔZn/ΔZn mouse platelets, metalloproteinase inhibitor GM6001, in vivo platelet clearance assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic ADAM17-null model combined with pharmacological inhibition, distinguished desialylation from shedding as independent clearance triggers","pmids":["22101895"],"is_preprint":false},{"year":2017,"finding":"Leukocyte integrin Mac-1 engages platelet GPIbα to promote thrombosis; Mac-1-deficient mice and mice with a Mac-1 mutation at the GPIbα-binding site show delayed thrombosis, and adoptive transfer of wild-type leukocytes rescues the defect. Mac-1:GPIbα interaction regulates the transcription factor Foxp1 in monocytes/macrophages.","method":"Mac-1 knockout mice, Mac-1 binding-site mutant mice, adoptive leukocyte transfer, carotid artery and cremaster microvascular injury models, small-molecule targeting","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models, adoptive transfer establishing cell-of-origin, downstream transcription factor identified, replicated across two injury models","pmids":["28555620"],"is_preprint":false},{"year":2018,"finding":"GPIbα is required for platelet-mediated hepatic thrombopoietin (TPO) generation; GPIbα-null mice and Bernard-Soulier syndrome patients have reduced circulating TPO due to decreased hepatic TPO mRNA transcription. The N-terminal extracellular domain of GPIbα is specifically required, and this function is independent of platelet desialylation. In vitro hepatocyte co-culture with GPIbα-coupled beads confirms direct GPIbα-dependent hepatocyte signaling.","method":"GPIbα-/- mouse model, BSS patient samples, platelet transfusion rescue experiments, hepatocyte co-culture with GPIbα-coupled beads, IL4R/GPIbα-transgenic mice, blocking antibodies","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple complementary genetic models (KO mice, transgenic, human BSS), in vitro reconstitution with GPIbα-beads, and rescue experiments establish mechanism","pmids":["29794068"],"is_preprint":false},{"year":2002,"finding":"GPIbα is essential for membrane development in maturing megakaryocytes; its absence leads to poorly developed demarcation membrane system, reduced internal membrane pool, abnormal proplatelet production, and ultimately macrothrombocytopenia. Rescue with human GPIbα transgene corrects all ultrastructural defects.","method":"Electron microscopy, immunogold labeling, computer-based membrane quantification in GPIbα-null and GPIbα-null/hTg rescue mice","journal":"Experimental Hematology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ultrastructural analysis with quantification in genetic KO and transgenic rescue model","pmids":["11937271"],"is_preprint":false},{"year":2024,"finding":"The GPIbα–filamin A interaction is required for demarcation membrane system (DMS) formation, correct subcellular distribution of filamin within megakaryocytes, and directional release of platelet buds into sinusoids; disrupting this interaction causes misdirected bud release into bone marrow interstitium and macrothrombocytopenia.","method":"Transgenic mouse model expressing filamin-binding-defective hGPIbα(FW), electron microscopy, intravital imaging of megakaryocytes","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — targeted mutagenesis in transgenic model with ultrastructural and functional characterization of DMS and bud release directionality","pmids":["37922495"],"is_preprint":false},{"year":2022,"finding":"The last 24 residues of the GPIbα intracellular tail (harboring 14-3-3 and PI3K binding sites) are required for VWF-dependent signaling (filopodia formation) and GPVI-mediated signaling (P-selectin exposure, αIIbβ3 activation, pSyk); deletion of this domain reduces platelet spreading on CRP and reduces platelet aggregate formation on collagen under shear, without affecting ligand binding or ADP/thrombin responses.","method":"CRISPR-Cas9 GPIbαΔsig/Δsig transgenic mouse, flow assays, immunoblotting (pSyk), platelet spreading and aggregation assays","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR-generated mouse model with multiple orthogonal functional assays establishing distinct signaling roles for the intracellular tail","pmids":["34134470"],"is_preprint":false},{"year":2003,"finding":"Thrombin binding to GPIbα (blocked by anti-GPIbα antibody VM16d or GPIbα cleavage by Mocarhagin) induces platelet aggregation via a signaling cascade independent of PAR-1 and PAR-4; this cascade activates Rho kinase p160ROCK (shape change), causes MEK-1 phosphorylation, and promotes fibrin binding to resting αIIbβ3, leading to fibrin-dependent platelet aggregation and clot retraction.","method":"PAR-desensitized platelets, function-blocking antibody, GPIbα-cleaving protease (Mocarhagin), signaling inhibitors, aggregometry","journal":"Thrombosis and Haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, multiple inhibitor tools but no genetic confirmation; mechanistic pathway defined pharmacologically","pmids":["12719784"],"is_preprint":false},{"year":2010,"finding":"GPIbα-selective activation (by multivalent VWF-A1/R543W-expressing COS-7 cells) triggers platelet aggregation through a signaling pathway dependent on Src, PI3K, and Syk, producing tyrosine phosphorylation patterns comparable to GPVI/collagen stimulation, establishing GPIbα as both an adhesion and signaling receptor.","method":"GPIbα-selective COS-7 cell agonist, kinase inhibitors, aggregometry, phosphorylation analysis with anti-Syk antibodies","journal":"Platelets","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, pharmacological dissection with selective agonist; Syk role later contested by separate study (PMID:28598382)","pmids":["20367574"],"is_preprint":false},{"year":2017,"finding":"Syk kinase activity is dispensable for VWF/GP1b-induced platelet adhesion, agglutination, aggregation, and secretion; selective Syk inhibitors (OXSI-2, PRT-060318) block GPVI- but not GP1b-mediated platelet activation and signaling.","method":"Selective Syk inhibitors, VWF-induced aggregation/adhesion assays, comparison with GPVI agonist CRP in human and mouse platelets","journal":"International Journal of Molecular Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, pharmacological approach; negative result mechanistically informative and contradicts prior reports from PMID:20367574","pmids":["28598382"],"is_preprint":false},{"year":2015,"finding":"GPIbα and PAR4 cooperate to generate thrombin-induced reactive oxygen species (ROS) in platelets via focal adhesion kinase (FAK) and NADPH oxidase 1 (NOX1); removal of the GPIbα ligand-binding region completely inhibits thrombin-induced ROS, and PAR4 deficiency abolishes it in mice.","method":"GPIbα-cleaving Naja kaouthia protease, PAR1/PAR4 antagonists, PAR4-deficient mice, flow cytometry ROS assay","journal":"Redox Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic tools (PAR4-KO mouse, GPIbα cleavage), two orthogonal inhibitor approaches identifying FAK/NOX1 pathway","pmids":["26569550"],"is_preprint":false},{"year":2010,"finding":"VWF self-associates on platelet GPIbα under hydrodynamic shear (>60–70 dyne/cm²), increasing effective VWF size and enhancing mechanotransduction and platelet activation through increased drag force on the receptor.","method":"Fluorescence-labeled VWF binding assays under shear, recombinant VWF lacking A1-domain (ΔA1-488), shear stress apparatus, whole blood flow assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, multiple biophysical tools but mechanistic model inferred from binding measurements without direct structural validation","pmids":["20696943"],"is_preprint":false},{"year":2010,"finding":"The thermodynamic mechanism of VWF A1–GPIbα binding involves catch-to-slip bond behavior coupled to A1 domain conformational unfolding; A1 binds GPIbα with ~20-fold higher affinity in an intermediate (partially unfolded) conformation, and force-induced dissociation shifts equilibrium toward this high-affinity state.","method":"Circular dichroism, thermodynamic binding analysis, allosteric binding model, reduction/carboxyamidation of A1 disulfide","journal":"Biophysical Journal","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with thermodynamic modeling, single lab, provides quantitative mechanistic framework","pmids":["20713003"],"is_preprint":false},{"year":2009,"finding":"Type 2B VWD mutations (R1306Q, I1309V) destabilize the A1 domain structure and lower the force threshold for catch-to-slip bond transition with GPIbα, while a type 2M mutation (G1324S) stabilizes A1 and raises this threshold; A1 conformational stability is allosterically coupled to force-dependent GPIbα binding kinetics.","method":"Protein unfolding thermodynamics, atomic force microscopy (single-bond dissociation kinetics), site-specific VWF mutations","journal":"Biophysical Journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with AFM force measurements and thermodynamic analysis of multiple disease-relevant mutations in a single study","pmids":["19619477"],"is_preprint":false},{"year":1999,"finding":"GPIbα interacts with the FcγRIIA receptor via residues R542G543R544 on GPIbα and D298D299D300 on FcγRIIA, suggesting that GPIb-IX-V signaling leading to platelet activation may be partially mediated through FcγRIIA.","method":"Yeast two-hybrid system, mutagenesis","journal":"Biochemical and Biophysical Research Communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — yeast two-hybrid with mutagenesis in a heterologous system, not validated in platelets; single lab, single method","pmids":["10581159"],"is_preprint":false},{"year":2022,"finding":"S100A8/A9 (calprotectin) induces formation of procoagulant (phosphatidylserine-positive) platelets by binding GPIbα; this was demonstrated using recombinant GPIbα ectodomain blockade, Bernard-Soulier syndrome platelets (GPIb-IX-V deficient), and mice lacking the extracellular domain of GPIbα, with a supporting role for CD36.","method":"Recombinant GPIbα ectodomain blockade, BSS patient platelets, GPIbα extracellular domain-deficient mice, flow cytometry, perfusion assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — three independent genetic/biological systems (BSS platelets, mouse KO, recombinant domain blockade) all confirm GPIbα as the S100A8/A9 receptor","pmids":["36026606"],"is_preprint":false},{"year":2019,"finding":"Platelet-derived extracellular vesicles transfer GPIbα to blood monocytes via P-selectin-dependent adhesion stabilized by phosphatidylserine binding; GPIbα-positive monocytes then tether and roll on immobilized VWF or adhere to TGF-β1-treated endothelium in a GPIbα-dependent manner, providing an alternative thrombo-inflammatory leukocyte recruitment pathway.","method":"Flow cytometry, intravital microscopy (cremaster, carotid), in vitro rolling assays, function-blocking anti-GPIbα antibody, mouse in vivo models","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 2 / Strong — antibody blockade, in vitro and in vivo experiments, multiple disease models (diesel nanoparticles, ApoE atherosclerosis, trauma) all consistent","pmids":["31467123"],"is_preprint":false},{"year":2019,"finding":"GPIbα-derived soluble protein produced by T cells acts through Mac-1 integrin on monocytes to stimulate PGE2, IL-1β, and IL-6 production in MDP-activated monocytes; anti-GPIbα or anti-Mac-1 antibody blockade inhibits this cytokine production, and recombinant GPIbα protein increases PGE2 production.","method":"Mass spectrometry identification, antibody blockade, recombinant GPIbα addition, Mac-1 KO mice in vivo, conditioned medium experiments","journal":"Science Signaling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS identification plus antibody blockade plus KO mice and recombinant protein, but novel/unexpected source of soluble GPIbα (T cells) warrants independent replication","pmids":["31594856"],"is_preprint":false},{"year":2016,"finding":"Specific inhibition of GPIbα shedding (using monoclonal antibody 5G6 Fab) during platelet storage preserves GPIbα surface levels and significantly improves post-transfusion platelet recovery and hemostatic function without altering platelet activation, degranulation, or aggregation, demonstrating that GPIbα shedding is a causal mechanism of storage-induced platelet clearance.","method":"Monoclonal antibody Fab fragment (5G6) specific for GPIbα shedding inhibition, room-temperature platelet storage, transfusion into mice, ex vivo thrombus formation under shear flow","journal":"Arteriosclerosis, Thrombosis, and Vascular Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — specific pharmacological inhibitor, human and transgenic mouse platelets, in vivo transfusion recovery and functional assays","pmids":["27417583"],"is_preprint":false},{"year":2023,"finding":"ADAM17 and its GPIbα substrate are both stored intracellularly in platelets, not on the surface; ADAM17 localizes to a distinct intracellular membrane system separate from α- and dense granules. Only a GPIbα subpopulation that becomes accessible after strong stimulation serves as ADAM17 substrate, and shedding occurs with kinetics (20 min–3 h) suggesting a role beyond hemostasis. Membrane-permeable ADAM17 inhibitors (but not proteinaceous inhibitors) can block shedding.","method":"Transmission electron microscopy with immunogold staining, immunoprecipitation, quantitative western blotting, selective inhibitors","journal":"Journal of Thrombosis and Haemostasis","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct ultrastructural localization with immunogold EM combined with biochemical studies defining two GPIbα subpopulations and spatial control of ADAM17 activity","pmids":["37001816"],"is_preprint":false},{"year":2022,"finding":"CLEC-2 deletion in platelets inhibits αIIbβ3 activation induced by VWF binding to GPIbα without preventing VWF binding itself, demonstrating that CLEC-2 acts downstream of GPIbα to mediate integrin activation and platelet aggregation in TTP-like conditions.","method":"Platelet-specific CLEC-2 knockout mice, VWF-binding assays, αIIbβ3 activation assays, mouse TTP model (anti-ADAMTS13 antibody + VWF infusion)","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO model with clearly separated binding vs. signaling steps, in vivo TTP model validates pathophysiological relevance","pmids":["35157766"],"is_preprint":false},{"year":2006,"finding":"A cell-penetrating peptide corresponding to GPIbα cytoplasmic residues 557–569 reduces VWF-dependent platelet adhesion and profoundly inhibits filopodia formation on VWF matrix, and abolishes shape change in CHO-GPIb-IX cells, demonstrating a functional role of this domain in VWF-dependent adhesion signaling.","method":"Cell-penetrating peptide (R9-coupled), platelet adhesion on VWF matrix, CHO-GPIb-IX cell adhesion assays, aggregometry","journal":"Journal of Thrombosis and Haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, peptide-based approach without genetic confirmation; validated in both platelets and heterologous cells","pmids":["17100656"],"is_preprint":false},{"year":2003,"finding":"The GPIbα Gly233Val gain-of-function mutation (platelet-type VWD) enhances formation and increases longevity of the GPIbα–VWF-A1 tether bond (k⁰off mutant 0.67 s⁻¹ vs. native 3.45 s⁻¹) without altering bond strength under applied force, promoting platelet adhesion at shear rates that do not support wild-type binding.","method":"Single-molecule kinetics of tether bond formation and dissociation using PT-VWD platelets, flow chamber assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous biophysical single-molecule assay with quantitative kinetics, single lab, human disease mutation","pmids":["12637314"],"is_preprint":false},{"year":1992,"finding":"The HPA-2 (Ko) alloantigens are located on GPIbα; the HPA-2b (Koa) allele encodes Met145 and HPA-2a (Kob) encodes Thr145, resulting from a C-T polymorphism at position 434 of the coding region. Anti-HPA-2a antibodies inhibit ristocetin-induced agglutination of HPA-2a-positive platelets, placing the epitope near the VWF-binding domain.","method":"PCR amplification and DNA sequencing, restriction fragment length polymorphism (RFLP), platelet agglutination inhibition assay","journal":"Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct sequencing of multiple donors, functional agglutination inhibition assay, and RFLP validation all consistent; foundational identification of the polymorphism","pmids":["1346615"],"is_preprint":false},{"year":2003,"finding":"The HPA-2 Thr145Met polymorphism affects VWF binding (HPA-2a/Thr145 binds VWF with higher affinity) but does not affect α-thrombin binding to GPIbα, indicating that the dimorphism modulates the conformation of the N-terminal flanking region and first leucine-rich repeat.","method":"Recombinant GPIbα N-terminal fragments (AA1-289) from CHO cells, resonant mirror binding studies, monoclonal antibody epitope mapping","journal":"Arteriosclerosis, Thrombosis, and Vascular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — recombinant protein binding assays and HPA-2 homozygous platelets, two methods, single lab","pmids":["12775575"],"is_preprint":false},{"year":2009,"finding":"Prolonged inhibition of protein kinase A (PKA) results in metalloproteinase-dependent GPIbα shedding from platelets; this is reversed by PKA activator forskolin, partially inhibited by calpain inhibitors, and completely blocked by metalloproteinase inhibitor GM6001, indicating PKA activity normally restrains ADAM17-mediated GPIbα cleavage.","method":"PKA inhibitor H89, PKA activator (forskolin), GM6001, calpain inhibitors, flow cytometry, VWF-dependent adhesion assays","journal":"Thrombosis Research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, pharmacological approach without genetic confirmation; multiple inhibitor tools used consistently","pmids":["19181367"],"is_preprint":false},{"year":2013,"finding":"Mitochondrial permeability transition pore (MPTP) opening triggers mitochondrial ROS production that promotes ADAM17-mediated GPIbα ectodomain shedding; mitochondrial Ca²⁺ uptake via MCU triggers MPTP opening, and both ROS and calpain contribute to shedding downstream of MPTP.","method":"MPTP inhibitor/potentiator, mitochondrial Ca²⁺ measurements, MCU inhibitor Ru360, BAPTA-AM, mitochondria-targeted ROS scavenger, calpain inhibitors, flow cytometry","journal":"Platelets","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, multiple pharmacological tools delineating pathway, but no genetic confirmation of individual steps","pmids":["23909816"],"is_preprint":false},{"year":2000,"finding":"Integrity of the leucine-rich repeat region of GPIbα is essential for normal glycosylation and surface expression of the GPIb-IX complex; the Nancy I mutation (deletion of Leu179) causes a 40% reduction in GPIbα molecular weight due to glycosylation deficiency, reduced surface expression, and complete loss of VWF binding and rolling on VWF surfaces.","method":"CHO cell transfection with wild-type and mutant GPIbα, flow cytometry, biochemical glycosylation analysis, static adhesion and perfusion assays on VWF","journal":"Thrombosis and Haemostasis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — heterologous expression with biochemical and functional readouts; natural disease mutation validates clinical relevance","pmids":["10928479"],"is_preprint":false},{"year":2022,"finding":"The O-glycosylated N-linker of VWF A1 reduces GPIbα binding affinity ~40-fold primarily through its O-glycan moiety and increases A1 thermal stability by raising the energy gap between native and intermediate states; the C-linker also decreases A1 affinity for GPIbα but has no effect on A1 stability or hydrogen-deuterium exchange, indicating distinct allosteric mechanisms for the two linkers.","method":"Binding affinity/kinetics measurements, thermodynamics, hydrogen-deuterium exchange (HDX), urea/temperature-induced unfolding, recombinant VWF A1 constructs","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods (HDX, thermodynamics, kinetics, stability), rigorous dissection of polypeptide vs. glycan contributions","pmids":["35532124"],"is_preprint":false}],"current_model":"GPIbα is the ligand-binding subunit of the platelet GPIb-IX-V complex that initiates hemostasis and thrombosis by binding VWF at sites of vascular injury via a catch-slip bond mechanism regulated by A1 domain conformation, interacts with thrombin exclusively at exosite II to recruit protease activity to the platelet surface, signals through its intracellular tail (via 14-3-3ζ, PI3K, and FAK/NOX1) to activate integrin αIIbβ3 and generate ROS in cooperation with PAR4 and CLEC-2, anchors the membrane skeleton through filamin A to maintain mechanical stability under shear and control megakaryocyte demarcation membrane system formation and platelet size, undergoes ADAM17-mediated ectodomain shedding from an intracellular GPIbα subpopulation triggered by strong stimulation (regulated by PKA, ROS, and MPTP), serves as the receptor for S100A8/A9 and fucoidan to induce procoagulant platelet formation, and mediates platelet-to-monocyte GPIbα transfer via extracellular vesicles to enable VWF-dependent inflammatory leukocyte recruitment, while also being required for platelet-mediated hepatic thrombopoietin generation through a direct hepatocyte interaction involving its N-terminal extracellular domain."},"narrative":{"mechanistic_narrative":"GPIbα is the ligand-binding subunit of the platelet GPIb-IX-V complex that initiates hemostasis and thrombosis by capturing von Willebrand factor (VWF) and recruiting thrombin to the platelet surface [PMID:17075060, PMID:24316004]. Its extracellular domain engages thrombin exclusively at anion-binding exosite II through residues D274–E285, leaving exosite I free for PAR-1 recognition [PMID:24316004, PMID:19591434], and the same complex can simultaneously bridge two thrombin molecules to scaffold adhesion [PMID:12855811]. Binding to VWF is governed by force-dependent catch-to-slip bond behavior coupled to A1-domain conformational unfolding, with A1 stability allosterically tuning the force threshold for engagement—a mechanism that disease-associated VWF and GPIbα mutations shift toward higher or lower affinity [PMID:20713003, PMID:19619477, PMID:12637314]. Engagement of GPIbα is essential and VWF-independent for platelet recruitment to subendothelium and growing thrombi under arterial flow [PMID:17075060]. Beyond adhesion, GPIbα is a signaling receptor: its intracellular tail binds 14-3-3ζ and PI3K to drive filopodia formation, αIIbβ3 activation, and platelet spreading, with these signals cooperating with GPVI, PAR4, and CLEC-2 downstream pathways including FAK/NOX1-dependent ROS generation [PMID:10627461, PMID:34134470, PMID:26569550, PMID:35157766]. The GPIbα cytoplasmic tail also anchors the membrane skeleton via filamin A, a coordinated interaction required for mechanical stability under shear, megakaryocyte demarcation membrane system formation, directional platelet release, and normal platelet size [PMID:21156842, PMID:22174152, PMID:11937271, PMID:37922495]; loss of GPIbα or its filamin link produces macrothrombocytopenia. GPIbα surface levels are controlled by ADAM17-mediated ectodomain shedding from an intracellular GPIbα subpopulation, a process restrained by PKA and triggered by desialylation, ROS, and mitochondrial permeability transition, and shedding is a causal driver of storage- and refrigeration-induced platelet clearance [PMID:15345652, PMID:22101895, PMID:37001816, PMID:19181367, PMID:23909816, PMID:27417583]. GPIbα additionally serves as the receptor for S100A8/A9 to generate procoagulant platelets [PMID:36026606], engages leukocyte Mac-1 to promote thrombosis and modulate monocyte transcription [PMID:28555620], can be transferred to monocytes via extracellular vesicles to enable VWF-dependent leukocyte recruitment [PMID:31467123], and is required for platelet-mediated hepatic thrombopoietin generation through a direct hepatocyte interaction of its N-terminal domain [PMID:29794068]. Loss-of-function in GPIbα underlies Bernard-Soulier syndrome, manifesting as reduced circulating TPO and macrothrombocytopenia [PMID:29794068].","teleology":[{"year":1992,"claim":"Establishing that the HPA-2 alloantigen system maps to a Thr145Met polymorphism on GPIbα localized the immunologically and clinically relevant epitope to the VWF-binding region.","evidence":"DNA sequencing, RFLP, and agglutination inhibition assay across donors","pmids":["1346615"],"confidence":"High","gaps":["Did not establish the functional consequence of the dimorphism for ligand binding","No structural localization within the N-terminal domain"]},{"year":2000,"claim":"Two studies defined the GPIbα cytoplasmic tail as a docking platform, showing residues 570–590 bind 14-3-3ζ under PKA regulation, answering how an adhesion receptor couples to intracellular signaling.","evidence":"Truncation mutagenesis, GST-pulldown, and co-IP in CHO cells and platelets; LRR-region glycosylation/expression analysis in CHO cells","pmids":["10627461","10928479"],"confidence":"High","gaps":["Downstream signaling consequences of 14-3-3ζ binding not resolved","Did not define how shear-induced dissociation is sensed"]},{"year":2002,"claim":"Demonstrating that GPIbα-null megakaryocytes have defective demarcation membrane systems established a developmental role for GPIbα in platelet biogenesis beyond hemostasis.","evidence":"Electron microscopy and immunogold quantification in GPIbα-null and human GPIbα transgenic rescue mice","pmids":["11937271"],"confidence":"High","gaps":["Did not identify the molecular effector linking GPIbα to membrane development","Mechanistic link to filamin not yet established at this stage"]},{"year":2003,"claim":"Structural and single-molecule work defined how GPIbα engages thrombin and how a gain-of-function mutation tunes the VWF tether bond, clarifying both the thrombin-recruitment scaffold and the kinetic basis of shear-dependent adhesion.","evidence":"X-ray crystallography of GPIbα–thrombin; single-molecule tether-bond kinetics of PT-VWD platelets; PAR-desensitized platelet signaling with blocking antibody and Mocarhagin","pmids":["12855811","12637314","12719784","12775575"],"confidence":"High","gaps":["Crystallographic dual-thrombin stoichiometry later refined to exosite-II-only binding","PAR-independent aggregation pathway defined only pharmacologically without genetic confirmation"]},{"year":2004,"claim":"Identifying ADAM17 as the metalloproteinase that sheds the GPIbα ectodomain established the enzymatic basis for surface receptor downregulation and platelet clearance.","evidence":"TACE-inactive chimeric mice, TACE inhibitors, and in vivo/in vitro shedding assays","pmids":["15345652"],"confidence":"High","gaps":["Did not define the physiological trigger or subcellular site of shedding","Upstream regulation of ADAM17 unresolved"]},{"year":2006,"claim":"Replacing the GPIbα ectodomain in vivo showed it is absolutely and VWF-independently required for platelet recruitment under arterial flow, establishing GPIbα as the indispensable adhesion initiator; a tail-derived peptide implicated cytoplasmic residues 557–569 in adhesion signaling.","evidence":"IL4Rα/GPIbα transgenic mice with intravital microscopy and adoptive transfer; cell-penetrating GPIbα(557–569) peptide in platelet and CHO adhesion assays","pmids":["17075060","17100656"],"confidence":"High","gaps":["Peptide approach lacked genetic confirmation","Nature of the VWF-independent adhesion ligand not defined"]},{"year":2009,"claim":"Biophysical mapping placed the thrombin interface at GPIbα residues D274–E285 on exosite II and showed PKA inhibition drives metalloproteinase-dependent shedding, beginning to delineate both the thrombin-binding chemistry and shedding regulation.","evidence":"NMR/AUC/HDX-MS of the thrombin interface; AFM and unfolding thermodynamics of VWD A1 mutants; PKA inhibitor/forskolin shedding assays","pmids":["19591434","19619477","19181367"],"confidence":"High","gaps":["PKA-shedding link defined pharmacologically without genetic confirmation","Mechanism connecting PKA to ADAM17 activity unresolved"]},{"year":2010,"claim":"A cluster of studies established the GPIbα–filamin A interaction as the membrane-skeleton anchor required for shear resistance, and defined the catch-slip thermodynamics and VWF self-association that govern force-dependent adhesion and mechanotransduction.","evidence":"Filamin-binding-defective hGPIbα(FW) transgenic mice under high shear; CD/thermodynamic A1 binding analysis; GPIbα-selective COS-7 agonist with kinase inhibitors; shear VWF self-association binding assays","pmids":["21156842","20713003","20367574","20696943"],"confidence":"High","gaps":["Syk dependence of GPIbα signaling later contested","Self-association model inferred from binding without structural validation"]},{"year":2011,"claim":"Linking GPIbα expression to filamin A trafficking and platelet size, and showing desialylation routes GPIbα to ADAM17 shedding and clearance, connected receptor biogenesis and turnover to platelet homeostasis.","evidence":"ESC-derived platelets and HEK293T trafficking assays; sialidase inhibitors with Adam17-null platelets and in vivo clearance assays","pmids":["22174152","22101895"],"confidence":"High","gaps":["Trafficking mechanism coordinating GPIbα and filamin not molecularly resolved","How desialylation exposes the cleavage site unclear"]},{"year":2013,"claim":"Refining the thrombin interface to exosite-II-only binding and identifying MPTP-driven mitochondrial ROS as a shedding trigger sharpened both the thrombin-recruitment model and the upstream control of GPIbα cleavage.","evidence":"Mutagenesis, crystallography, and NMR of thrombin binding; MPTP/MCU pharmacology and mitochondrial ROS measurements for shedding","pmids":["24316004","23909816"],"confidence":"High","gaps":["MPTP-shedding pathway defined pharmacologically without genetic confirmation of individual steps","Physiological context triggering MPTP-dependent shedding unclear"]},{"year":2015,"claim":"Demonstrating that GPIbα cooperates with PAR4 via FAK and NOX1 to generate thrombin-induced ROS placed GPIbα within a redox signaling node downstream of platelet activation.","evidence":"GPIbα-cleaving protease, PAR antagonists, PAR4-deficient mice, and flow cytometric ROS assays","pmids":["26569550"],"confidence":"Medium","gaps":["Direct physical coupling between GPIbα and the FAK/NOX1 module not shown","Pharmacological dissection without GPIbα genetic confirmation"]},{"year":2017,"claim":"Two studies extended GPIbα biology to leukocyte engagement via Mac-1 and resolved the contested role of Syk, showing Syk activity is dispensable for VWF/GPIbα-induced platelet responses.","evidence":"Mac-1 knockout and binding-site mutant mice with adoptive transfer and injury models; selective Syk inhibitors comparing GPIbα versus GPVI signaling","pmids":["28555620","28598382"],"confidence":"High","gaps":["Syk negative result derived from a single pharmacological study","Molecular consequences of Mac-1–GPIbα binding for monocyte Foxp1 not fully resolved"]},{"year":2018,"claim":"Establishing that the GPIbα N-terminal domain is required for platelet-driven hepatic thrombopoietin generation revealed a homeostatic feedback role linking platelet receptor to TPO production.","evidence":"GPIbα-null and IL4R/GPIbα transgenic mice, BSS patient samples, transfusion rescue, and hepatocyte co-culture with GPIbα-coupled beads","pmids":["29794068"],"confidence":"High","gaps":["Hepatocyte receptor/partner for GPIbα not identified","Signaling pathway driving hepatic TPO transcription unresolved"]},{"year":2019,"claim":"Discovery that GPIbα can be transferred to monocytes via extracellular vesicles, and that a soluble T-cell-derived GPIbα acts through Mac-1, expanded GPIbα function into thrombo-inflammatory leukocyte recruitment and cytokine signaling.","evidence":"Flow cytometry, intravital and in vitro rolling assays with anti-GPIbα blockade; MS identification, recombinant GPIbα, antibody blockade, and Mac-1 KO mice","pmids":["31467123","31594856"],"confidence":"Medium","gaps":["T-cell as a source of soluble GPIbα warrants independent replication","Receptor mechanism on hepatocytes/leukocytes incompletely defined"]},{"year":2022,"claim":"A set of studies established CLEC-2 as a downstream effector of GPIbα-driven integrin activation, identified GPIbα as the S100A8/A9 receptor for procoagulant platelet formation, and dissected how VWF A1 linkers allosterically tune GPIbα affinity.","evidence":"Platelet-specific CLEC-2 KO mice with TTP model; GPIbα ectodomain blockade, BSS platelets, and GPIbα-deficient mice; HDX and thermodynamic analysis of A1 linker constructs","pmids":["35157766","36026606","35532124"],"confidence":"High","gaps":["Physical coupling between GPIbα and CLEC-2 not defined","Mechanism translating S100A8/A9 binding into phosphatidylserine exposure unresolved"]},{"year":2023,"claim":"Demonstrating that ADAM17 and a GPIbα substrate subpopulation are stored intracellularly redefined shedding as a spatially controlled event requiring strong stimulation rather than constitutive surface cleavage.","evidence":"Immunogold transmission EM, immunoprecipitation, quantitative western blotting, and membrane-permeable versus proteinaceous ADAM17 inhibitors","pmids":["37001816"],"confidence":"High","gaps":["Trafficking route exposing the intracellular GPIbα subpopulation unclear","The non-hemostatic function implied by slow shedding kinetics not defined"]},{"year":2024,"claim":"Showing the GPIbα–filamin A interaction directs demarcation membrane formation and the directional release of platelet buds into sinusoids linked the membrane-skeleton anchor to spatially controlled thrombopoiesis.","evidence":"Filamin-binding-defective hGPIbα(FW) transgenic mice with electron microscopy and intravital megakaryocyte imaging","pmids":["37922495"],"confidence":"High","gaps":["Molecular cue establishing release directionality not identified","How filamin redistribution is regulated by the GPIbα link unresolved"]},{"year":null,"claim":"The identity of the hepatocyte receptor mediating GPIbα-dependent thrombopoietin generation and the molecular pathway coupling GPIbα adhesion signaling to its multiple cooperating receptors (CLEC-2, PAR4, FAK/NOX1) remain to be defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No identified hepatocyte partner for GPIbα N-terminal domain","Physical basis of GPIbα–CLEC-2 functional coupling unknown","Mechanism integrating GPIbα signaling with redox and procoagulant outputs incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[4,19,29]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[13,15,17,27]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[6,7,12]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[22]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,6,26]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[6,7,12]}],"pathway":[{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[4,0,1]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,13,17]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,23,24]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[11,12]}],"complexes":["GPIb-IX-V complex"],"partners":["VWF","THROMBIN","FILAMIN A","14-3-3Ζ","PI3K","MAC-1","S100A8/A9","CLEC-2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P07359","full_name":"Platelet glycoprotein Ib alpha chain","aliases":["Antigen CD42b-alpha"],"length_aa":652,"mass_kda":71.5,"function":"GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/P07359/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GP1BA","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GP1BA","total_profiled":1310},"omim":[{"mim_id":"621264","title":"FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA 1; FMAIT1","url":"https://www.omim.org/entry/621264"},{"mim_id":"620776","title":"THROMBOCYTOPENIA 13, SYNDROMIC; THC13","url":"https://www.omim.org/entry/620776"},{"mim_id":"613554","title":"VON WILLEBRAND DISEASE, TYPE 2; VWD2","url":"https://www.omim.org/entry/613554"},{"mim_id":"613160","title":"VON WILLEBRAND FACTOR; VWF","url":"https://www.omim.org/entry/613160"},{"mim_id":"608631","title":"ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2","url":"https://www.omim.org/entry/608631"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":4.6},{"tissue":"lymphoid tissue","ntpm":13.7}],"url":"https://www.proteinatlas.org/search/GP1BA"},"hgnc":{"alias_symbol":["HPA-2","CD42b","GPIbalpha"],"prev_symbol":["GP1B"]},"alphafold":{"accession":"P07359","domains":[{"cath_id":"3.80.10.10","chopping":"34-191","consensus_level":"medium","plddt":96.9609,"start":34,"end":191},{"cath_id":"3.80.10.10","chopping":"203-285","consensus_level":"medium","plddt":91.5276,"start":203,"end":285}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P07359","model_url":"https://alphafold.ebi.ac.uk/files/AF-P07359-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P07359-F1-predicted_aligned_error_v6.png","plddt_mean":64.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GP1BA","jax_strain_url":"https://www.jax.org/strain/search?query=GP1BA"},"sequence":{"accession":"P07359","fasta_url":"https://rest.uniprot.org/uniprotkb/P07359.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P07359/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P07359"}},"corpus_meta":[{"pmid":"30936549","id":"PMC_30936549","title":"Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.","date":"2019","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30936549","citation_count":341,"is_preprint":false},{"pmid":"9449713","id":"PMC_9449713","title":"Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9449713","citation_count":322,"is_preprint":false},{"pmid":"15345652","id":"PMC_15345652","title":"Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo.","date":"2004","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15345652","citation_count":191,"is_preprint":false},{"pmid":"17075060","id":"PMC_17075060","title":"The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17075060","citation_count":181,"is_preprint":false},{"pmid":"22101895","id":"PMC_22101895","title":"Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22101895","citation_count":163,"is_preprint":false},{"pmid":"28555620","id":"PMC_28555620","title":"Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28555620","citation_count":141,"is_preprint":false},{"pmid":"12855811","id":"PMC_12855811","title":"Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12855811","citation_count":132,"is_preprint":false},{"pmid":"1346615","id":"PMC_1346615","title":"NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens.","date":"1992","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/1346615","citation_count":131,"is_preprint":false},{"pmid":"9227689","id":"PMC_9227689","title":"Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke.","date":"1997","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/9227689","citation_count":108,"is_preprint":false},{"pmid":"36026606","id":"PMC_36026606","title":"S100A8/A9 drives the formation of procoagulant platelets through GPIbα.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/36026606","citation_count":83,"is_preprint":false},{"pmid":"31467123","id":"PMC_31467123","title":"Appropriation of GPIbα from platelet-derived extracellular vesicles supports monocyte recruitment in systemic inflammation.","date":"2019","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/31467123","citation_count":80,"is_preprint":false},{"pmid":"21933849","id":"PMC_21933849","title":"Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation).","date":"2011","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/21933849","citation_count":80,"is_preprint":false},{"pmid":"22019589","id":"PMC_22019589","title":"The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/22019589","citation_count":77,"is_preprint":false},{"pmid":"11514372","id":"PMC_11514372","title":"Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death.","date":"2001","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/11514372","citation_count":71,"is_preprint":false},{"pmid":"20696943","id":"PMC_20696943","title":"von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20696943","citation_count":69,"is_preprint":false},{"pmid":"21156842","id":"PMC_21156842","title":"High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21156842","citation_count":68,"is_preprint":false},{"pmid":"29794068","id":"PMC_29794068","title":"GPIbα is required for platelet-mediated hepatic thrombopoietin generation.","date":"2018","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/29794068","citation_count":65,"is_preprint":false},{"pmid":"11937271","id":"PMC_11937271","title":"Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model.","date":"2002","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11937271","citation_count":65,"is_preprint":false},{"pmid":"26569550","id":"PMC_26569550","title":"Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.","date":"2015","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/26569550","citation_count":61,"is_preprint":false},{"pmid":"27417583","id":"PMC_27417583","title":"Inhibiting GPIbα Shedding Preserves Post-Transfusion Recovery and Hemostatic Function of Platelets After Prolonged Storage.","date":"2016","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27417583","citation_count":56,"is_preprint":false},{"pmid":"30429161","id":"PMC_30429161","title":"The Gp1ba-Cre transgenic mouse: a new model to delineate platelet and leukocyte functions.","date":"2018","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30429161","citation_count":52,"is_preprint":false},{"pmid":"12637314","id":"PMC_12637314","title":"Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12637314","citation_count":51,"is_preprint":false},{"pmid":"10627461","id":"PMC_10627461","title":"Cytoplasmic domains of GpIbalpha and GpIbbeta regulate 14-3-3zeta binding to GpIb/IX/V.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10627461","citation_count":50,"is_preprint":false},{"pmid":"18815197","id":"PMC_18815197","title":"Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant.","date":"2008","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/18815197","citation_count":46,"is_preprint":false},{"pmid":"32556282","id":"PMC_32556282","title":"Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/32556282","citation_count":44,"is_preprint":false},{"pmid":"22174152","id":"PMC_22174152","title":"GPIbα regulates platelet size by controlling the subcellular localization of filamin.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22174152","citation_count":43,"is_preprint":false},{"pmid":"20955404","id":"PMC_20955404","title":"Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy.","date":"2010","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/20955404","citation_count":42,"is_preprint":false},{"pmid":"20367574","id":"PMC_20367574","title":"GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.","date":"2010","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/20367574","citation_count":40,"is_preprint":false},{"pmid":"7648675","id":"PMC_7648675","title":"VCL, an antagonist of the platelet GP1b receptor, markedly inhibits platelet adhesion and intimal thickening after balloon injury in the rat.","date":"1995","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/7648675","citation_count":39,"is_preprint":false},{"pmid":"30312492","id":"PMC_30312492","title":"Comparison between manufacturing sites shows differential adhesion, activation, and GPIbα expression of cryopreserved platelets.","date":"2018","source":"Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/30312492","citation_count":38,"is_preprint":false},{"pmid":"32157300","id":"PMC_32157300","title":"Mechanisms of anti-GPIbα antibody-induced thrombocytopenia in mice.","date":"2020","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/32157300","citation_count":37,"is_preprint":false},{"pmid":"21552524","id":"PMC_21552524","title":"GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21552524","citation_count":37,"is_preprint":false},{"pmid":"29325217","id":"PMC_29325217","title":"Neutrophil infiltration to the brain is platelet-dependent, and is reversed by blockade of platelet GPIbα.","date":"2018","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29325217","citation_count":35,"is_preprint":false},{"pmid":"20713003","id":"PMC_20713003","title":"The mechanism of VWF-mediated platelet GPIbalpha binding.","date":"2010","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20713003","citation_count":35,"is_preprint":false},{"pmid":"11410606","id":"PMC_11410606","title":"High-resolution CryoFESEM of individual cell adhesion molecules (CAMs) in the glycocalyx of human platelets: detection of P-selectin (CD62P), GPI-IX complex (CD42A/CD42B alpha,B beta), and integrin GPIIbIIIa (CD41/CD61) by immunogold labeling and stereo imaging.","date":"2001","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/11410606","citation_count":34,"is_preprint":false},{"pmid":"19619477","id":"PMC_19619477","title":"Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.","date":"2009","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19619477","citation_count":34,"is_preprint":false},{"pmid":"24316004","id":"PMC_24316004","title":"GpIbα interacts exclusively with exosite II of thrombin.","date":"2013","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24316004","citation_count":33,"is_preprint":false},{"pmid":"12775575","id":"PMC_12775575","title":"von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.","date":"2003","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12775575","citation_count":33,"is_preprint":false},{"pmid":"30223883","id":"PMC_30223883","title":"Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction.","date":"2018","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30223883","citation_count":32,"is_preprint":false},{"pmid":"15569237","id":"PMC_15569237","title":"Real-time PCR genotyping of human platelet alloantigens HPA-1, HPA-2, HPA-3 and HPA-5 is superior to the standard PCR-SSP method.","date":"2004","source":"Transfusion medicine (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15569237","citation_count":32,"is_preprint":false},{"pmid":"12719784","id":"PMC_12719784","title":"Thrombin binding to GPIbalpha induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin.","date":"2003","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/12719784","citation_count":31,"is_preprint":false},{"pmid":"33468191","id":"PMC_33468191","title":"Anti-platelet aggregation of Panax notoginseng triol saponins by regulating GP1BA for ischemic stroke therapy.","date":"2021","source":"Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33468191","citation_count":30,"is_preprint":false},{"pmid":"7900082","id":"PMC_7900082","title":"Association of a variable number of tandem repeats (VNTR) in glycoprotein Ib alpha and HPA-2 alloantigens.","date":"1994","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/7900082","citation_count":30,"is_preprint":false},{"pmid":"10607704","id":"PMC_10607704","title":"Threonine-145/methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbalpha express HPA-2 epitopes and show equal binding of von Willebrand factor.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10607704","citation_count":29,"is_preprint":false},{"pmid":"16519708","id":"PMC_16519708","title":"Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura.","date":"2006","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/16519708","citation_count":28,"is_preprint":false},{"pmid":"23014764","id":"PMC_23014764","title":"A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease.","date":"2012","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/23014764","citation_count":27,"is_preprint":false},{"pmid":"1370207","id":"PMC_1370207","title":"Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ib alpha.","date":"1992","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/1370207","citation_count":25,"is_preprint":false},{"pmid":"30700416","id":"PMC_30700416","title":"Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.","date":"2019","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/30700416","citation_count":24,"is_preprint":false},{"pmid":"10581159","id":"PMC_10581159","title":"Interaction between GPIbalpha and FcgammaIIA receptor in human platelets.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10581159","citation_count":24,"is_preprint":false},{"pmid":"29976871","id":"PMC_29976871","title":"Dengue Virus Induces the Release of sCD40L and Changes in Levels of Membranal CD42b and CD40L Molecules in Human Platelets.","date":"2018","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/29976871","citation_count":23,"is_preprint":false},{"pmid":"31519182","id":"PMC_31519182","title":"cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.","date":"2019","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/31519182","citation_count":22,"is_preprint":false},{"pmid":"34134470","id":"PMC_34134470","title":"The GPIbα intracellular tail - role in transducing VWF- and collagen/GPVI-mediated signaling.","date":"2022","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/34134470","citation_count":22,"is_preprint":false},{"pmid":"18383324","id":"PMC_18383324","title":"Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke.","date":"2008","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/18383324","citation_count":22,"is_preprint":false},{"pmid":"24474090","id":"PMC_24474090","title":"Identification of p.W246L as a novel mutation in the GP1BA gene responsible for platelet-type von Willebrand disease.","date":"2014","source":"Seminars in thrombosis and hemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/24474090","citation_count":21,"is_preprint":false},{"pmid":"35157766","id":"PMC_35157766","title":"Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/35157766","citation_count":20,"is_preprint":false},{"pmid":"24635452","id":"PMC_24635452","title":"Targeting the GPIbα binding site of thrombin to simultaneously induce dual anticoagulant and antiplatelet effects.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24635452","citation_count":20,"is_preprint":false},{"pmid":"36732162","id":"PMC_36732162","title":"Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα.","date":"2023","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/36732162","citation_count":19,"is_preprint":false},{"pmid":"33220290","id":"PMC_33220290","title":"Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33220290","citation_count":19,"is_preprint":false},{"pmid":"11077115","id":"PMC_11077115","title":"Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow.","date":"2000","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/11077115","citation_count":19,"is_preprint":false},{"pmid":"17100656","id":"PMC_17100656","title":"Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide.","date":"2006","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/17100656","citation_count":19,"is_preprint":false},{"pmid":"19591434","id":"PMC_19591434","title":"Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19591434","citation_count":18,"is_preprint":false},{"pmid":"9358621","id":"PMC_9358621","title":"Gene frequencies of the HPA-1 and HPA-2 platelet antigen alleles among the Amerindians.","date":"1997","source":"Vox sanguinis","url":"https://pubmed.ncbi.nlm.nih.gov/9358621","citation_count":18,"is_preprint":false},{"pmid":"38299614","id":"PMC_38299614","title":"GPIbα CAAR T cells function like a Trojan horse to eliminate autoreactive B cells to treat immune thrombocytopenia.","date":"2024","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/38299614","citation_count":17,"is_preprint":false},{"pmid":"33977209","id":"PMC_33977209","title":"GPIbα is the driving force of hepatic thrombopoietin generation.","date":"2021","source":"Research and practice in thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/33977209","citation_count":16,"is_preprint":false},{"pmid":"10928479","id":"PMC_10928479","title":"Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.","date":"2000","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/10928479","citation_count":16,"is_preprint":false},{"pmid":"37001816","id":"PMC_37001816","title":"GPIbα shedding in platelets is controlled by strict intracellular containment of both enzyme and substrate.","date":"2023","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/37001816","citation_count":15,"is_preprint":false},{"pmid":"31005062","id":"PMC_31005062","title":"The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-Mediated Platelet Aggregation.","date":"2019","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/31005062","citation_count":15,"is_preprint":false},{"pmid":"14961160","id":"PMC_14961160","title":"Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: involvement of platelet GPIbalpha and neutrophil PSGL-1.","date":"2004","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/14961160","citation_count":15,"is_preprint":false},{"pmid":"37922495","id":"PMC_37922495","title":"GPIbα-filamin A interaction regulates megakaryocyte localization and budding during platelet biogenesis.","date":"2024","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37922495","citation_count":14,"is_preprint":false},{"pmid":"10555746","id":"PMC_10555746","title":"The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar.","date":"1999","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10555746","citation_count":14,"is_preprint":false},{"pmid":"21993687","id":"PMC_21993687","title":"A A386G biallelic GPIbα gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis.","date":"2011","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/21993687","citation_count":14,"is_preprint":false},{"pmid":"30609275","id":"PMC_30609275","title":"The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.","date":"2019","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/30609275","citation_count":14,"is_preprint":false},{"pmid":"11776304","id":"PMC_11776304","title":"Compound heterozygosity of the GPIbalpha gene associated with Bernard-Soulier syndrome.","date":"2001","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/11776304","citation_count":14,"is_preprint":false},{"pmid":"19181367","id":"PMC_19181367","title":"Prolonged inhibition of protein kinase A results in metalloproteinase-dependent platelet GPIbalpha shedding.","date":"2009","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/19181367","citation_count":13,"is_preprint":false},{"pmid":"30445311","id":"PMC_30445311","title":"Increased GPIbα shedding from platelets treated with immune thrombocytopenia plasma.","date":"2018","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30445311","citation_count":13,"is_preprint":false},{"pmid":"28953486","id":"PMC_28953486","title":"Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support.","date":"2018","source":"ASAIO journal (American Society for Artificial Internal Organs : 1992)","url":"https://pubmed.ncbi.nlm.nih.gov/28953486","citation_count":12,"is_preprint":false},{"pmid":"25293780","id":"PMC_25293780","title":"Exploiting the kinetic interplay between GPIbα-VWF binding interfaces to regulate hemostasis and thrombosis.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25293780","citation_count":12,"is_preprint":false},{"pmid":"23909816","id":"PMC_23909816","title":"The role of mitochondrial permeability transition pore in regulating the shedding of the platelet GPIbα ectodomain.","date":"2013","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/23909816","citation_count":12,"is_preprint":false},{"pmid":"34333846","id":"PMC_34333846","title":"The Copenhagen founder variant GP1BA c.58T>G is the most frequent cause of inherited thrombocytopenia in Denmark.","date":"2021","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/34333846","citation_count":11,"is_preprint":false},{"pmid":"22542759","id":"PMC_22542759","title":"Diesel exhaust particles impair platelet response to collagen and are associated with GPIbα shedding.","date":"2012","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/22542759","citation_count":11,"is_preprint":false},{"pmid":"18051299","id":"PMC_18051299","title":"Characterization and purification of acidocin 1B, a bacteriocin produced by Lactobacillus acidophilus GP1B.","date":"2007","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/18051299","citation_count":11,"is_preprint":false},{"pmid":"30332551","id":"PMC_30332551","title":"A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome.","date":"2018","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/30332551","citation_count":10,"is_preprint":false},{"pmid":"33548391","id":"PMC_33548391","title":"A fibrinolytic snake venom metalloproteinase, mutalysin-II, with antiplatelet activity and targeting capability toward glycoprotein GPIbα and glycoprotein GPVI.","date":"2021","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/33548391","citation_count":10,"is_preprint":false},{"pmid":"33284729","id":"PMC_33284729","title":"Platelet surface GPIbα, activated GPIIb-IIIa, and P-selectin levels in adult veno-arterial extracorporeal membrane oxygenation patients.","date":"2020","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/33284729","citation_count":9,"is_preprint":false},{"pmid":"35532124","id":"PMC_35532124","title":"Von Willebrand factor A1 domain stability and affinity for GPIbα are differentially regulated by its O-glycosylated N- and C-linker.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/35532124","citation_count":9,"is_preprint":false},{"pmid":"28598382","id":"PMC_28598382","title":"Syk Activity Is Dispensable for Platelet GP1b-IX-V Signaling.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28598382","citation_count":8,"is_preprint":false},{"pmid":"17619827","id":"PMC_17619827","title":"Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men.","date":"2007","source":"Journal of thrombosis and thrombolysis","url":"https://pubmed.ncbi.nlm.nih.gov/17619827","citation_count":8,"is_preprint":false},{"pmid":"27683759","id":"PMC_27683759","title":"A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B \"Malmö/New York\" von Willebrand disease.","date":"2016","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/27683759","citation_count":8,"is_preprint":false},{"pmid":"26849716","id":"PMC_26849716","title":"A novel mutation in GP1BA gene leads to mono-allelic Bernard Soulier syndrome form of macrothrombocytopenia.","date":"2017","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/26849716","citation_count":7,"is_preprint":false},{"pmid":"36031231","id":"PMC_36031231","title":"Guanxinning tablet inhibits the interaction between leukocyte integrin Mac-1 and platelet GPIbα for antithrombosis without increased bleeding risk.","date":"2022","source":"Chinese journal of natural medicines","url":"https://pubmed.ncbi.nlm.nih.gov/36031231","citation_count":7,"is_preprint":false},{"pmid":"33968982","id":"PMC_33968982","title":"MD Simulations on a Well-Built Docking Model Reveal Fine Mechanical Stability and Force-Dependent Dissociation of Mac-1/GPIbα Complex.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33968982","citation_count":7,"is_preprint":false},{"pmid":"31594856","id":"PMC_31594856","title":"T cell-derived soluble glycoprotein GPIbα mediates PGE2 production in human monocytes activated with the vaccine adjuvant MDP.","date":"2019","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/31594856","citation_count":6,"is_preprint":false},{"pmid":"23771674","id":"PMC_23771674","title":"Changes in platelet GPIbα and ADAM17 during the acute stage of atherosclerotic ischemic stroke among Chinese.","date":"2013","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/23771674","citation_count":6,"is_preprint":false},{"pmid":"18791947","id":"PMC_18791947","title":"A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding.","date":"2008","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/18791947","citation_count":6,"is_preprint":false},{"pmid":"23260446","id":"PMC_23260446","title":"Histamine reduces GPIbα-mediated adhesion of platelets to TNF-α-activated vascular endothelium.","date":"2012","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/23260446","citation_count":6,"is_preprint":false},{"pmid":"37180784","id":"PMC_37180784","title":"Platelet accumulation in an endothelium-coated elastic vein valve model of deep vein thrombosis is mediated by GPIbα-VWF interaction.","date":"2023","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37180784","citation_count":6,"is_preprint":false},{"pmid":"23072895","id":"PMC_23072895","title":"An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction.","date":"2012","source":"Chemical communications (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23072895","citation_count":6,"is_preprint":false},{"pmid":"38660804","id":"PMC_38660804","title":"Differential Impact In Vivo of Pf4-ΔCre-Mediated and Gp1ba-ΔCre-Mediated Depletion of Cyclooxygenase-1 in Platelets in Mice.","date":"2024","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38660804","citation_count":5,"is_preprint":false},{"pmid":"38889268","id":"PMC_38889268","title":"Reduction of ristocetin-induced platelet aggregation (RIPA) during storage despite plasma renewal: evidence for hemostatic importance of GPIbα shedding.","date":"2024","source":"Expert review of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/38889268","citation_count":5,"is_preprint":false},{"pmid":"26646710","id":"PMC_26646710","title":"The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates.","date":"2015","source":"Vox sanguinis","url":"https://pubmed.ncbi.nlm.nih.gov/26646710","citation_count":5,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55455,"output_tokens":9139,"usd":0.151725,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19763,"output_tokens":6201,"usd":0.12692,"stage2_stop_reason":"end_turn"},"total_usd":0.278645,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Crystal structure of the GPIbα–thrombin complex at 2.6 Å resolution reveals that GPIbα simultaneously contacts exosite I of one thrombin molecule and exosite II of a second thrombin molecule, providing a scaffold that could drive tight platelet adhesion.\",\n      \"method\": \"X-ray crystallography (2.6 Å resolution)\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure with direct identification of two distinct binding interfaces; foundational structural paper replicated and refined by subsequent studies\",\n      \"pmids\": [\"12855811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GPIbα binds exclusively to thrombin's anion-binding exosite II (not exosite I), serving to recruit thrombin to the platelet surface while leaving exosite I free for PAR-1 recognition; demonstrated by mutational analysis, binding studies, X-ray crystallography, and NMR.\",\n      \"method\": \"Mutational analysis, binding studies, X-ray crystallography, NMR spectroscopy\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (mutagenesis, crystallography, NMR) in a single rigorous study, with clear functional implication for PAR-1 activation\",\n      \"pmids\": [\"24316004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NMR, AUC, and hydrogen-deuterium exchange studies show that GPIbα residues D274–E285 interact with thrombin's anion-binding exosite II in an extended conformation with 1:1 stoichiometry, and binding causes long-range conformational effects on thrombin.\",\n      \"method\": \"1D/2D NMR, analytical ultracentrifugation, hydrogen-deuterium exchange coupled with MALDI-TOF MS\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods in a single study defining the binding interface at residue resolution\",\n      \"pmids\": [\"19591434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ADAM17 (TACE) is the key metalloproteinase mediating ectodomain shedding of GPIbα in platelets; TACE-deficient chimeric mice show ~90% reduction in soluble glycocalicin in plasma, increased surface GPIbα, and improved post-transfusion recovery and hemostatic function of damaged platelets.\",\n      \"method\": \"Chimeric mouse model with inactive TACE (TACEΔZn/ΔZn), TACE inhibitors (TAP1, TMI-1), in vivo and in vitro shedding assays\",\n      \"journal\": \"Circulation Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function model combined with pharmacological inhibition, replicated across mouse and human platelets with multiple functional readouts\",\n      \"pmids\": [\"15345652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"GPIbα is absolutely required for platelet recruitment to exposed subendothelium and to growing thrombi under arterial flow conditions, independent of VWF binding; transgenic mice expressing GPIbα with the extracellular domain replaced by IL-4Rα showed virtually absent platelet adhesion and completely inhibited arterial thrombus formation.\",\n      \"method\": \"Transgenic mouse model (IL4Rα/GPIbα-tg), intravital microscopy of mesenteric arterioles, adoptive transfer experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — well-controlled genetic model with direct in vivo intravital imaging and adoptive transfer experiments demonstrating GPIbα-specific mechanism\",\n      \"pmids\": [\"17075060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The cytoplasmic domain of GPIbα (residues 570–590) is required for binding 14-3-3ζ; deletion of Trp570–Ser590 eliminates 14-3-3ζ binding. PKA-dependent phosphorylation of GPIbβ enhances 14-3-3ζ binding to the GPIb/IX/V complex. Under shear stress-induced platelet aggregation, 14-3-3ζ dissociates from GPIbα.\",\n      \"method\": \"Truncation/deletion mutagenesis, GST-pulldown, co-immunoprecipitation in CHO cells and human platelets, shear stress assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pulldown and co-IP with structure-function mutagenesis, validated in both heterologous cells and native platelets\",\n      \"pmids\": [\"10627461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The GPIbα–filamin A interaction is essential for maintaining membrane skeletal stability under high shear stress; disrupting this interaction (Phe568Ala/Trp570Ala mutations in human GPIbα) leads to unstable membrane tethers, defective platelet adhesion, and membrane disintegration at pathological shear rates (5,000–40,000 s⁻¹), without altering intrinsic ligand-binding function or integrin αIIbβ3-dependent spreading.\",\n      \"method\": \"Transgenic mouse model expressing filamin-binding-defective hGPIbα(FW), high-shear flow assays, intravital microscopy\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — targeted mutagenesis in transgenic mouse model with multiple functional readouts under defined shear conditions\",\n      \"pmids\": [\"21156842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GPIbα regulates platelet size by controlling the subcellular localization of filamin A; coordinated expression of GPIbα and filamin is required for efficient trafficking of either protein to the cell surface, and their ratio determines normal proplatelet/platelet size.\",\n      \"method\": \"Embryonic stem cell differentiation into platelets, filamin knockdown, GPIbα overexpression, HEK293T trafficking assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple complementary cell models (ESC-derived platelets, HEK293T), genetic manipulation of both proteins, mechanistic link to trafficking demonstrated\",\n      \"pmids\": [\"22174152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Desialylation of GPIbα by platelet sialidases (Neu1, Neu3) after refrigeration targets it for ADAM17-mediated ectodomain shedding; desialylation alone (without metalloproteinase-mediated shedding) is sufficient to cause rapid clearance of platelets from circulation.\",\n      \"method\": \"Sialidase inhibitor studies, Adam17ΔZn/ΔZn mouse platelets, metalloproteinase inhibitor GM6001, in vivo platelet clearance assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic ADAM17-null model combined with pharmacological inhibition, distinguished desialylation from shedding as independent clearance triggers\",\n      \"pmids\": [\"22101895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Leukocyte integrin Mac-1 engages platelet GPIbα to promote thrombosis; Mac-1-deficient mice and mice with a Mac-1 mutation at the GPIbα-binding site show delayed thrombosis, and adoptive transfer of wild-type leukocytes rescues the defect. Mac-1:GPIbα interaction regulates the transcription factor Foxp1 in monocytes/macrophages.\",\n      \"method\": \"Mac-1 knockout mice, Mac-1 binding-site mutant mice, adoptive leukocyte transfer, carotid artery and cremaster microvascular injury models, small-molecule targeting\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models, adoptive transfer establishing cell-of-origin, downstream transcription factor identified, replicated across two injury models\",\n      \"pmids\": [\"28555620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GPIbα is required for platelet-mediated hepatic thrombopoietin (TPO) generation; GPIbα-null mice and Bernard-Soulier syndrome patients have reduced circulating TPO due to decreased hepatic TPO mRNA transcription. The N-terminal extracellular domain of GPIbα is specifically required, and this function is independent of platelet desialylation. In vitro hepatocyte co-culture with GPIbα-coupled beads confirms direct GPIbα-dependent hepatocyte signaling.\",\n      \"method\": \"GPIbα-/- mouse model, BSS patient samples, platelet transfusion rescue experiments, hepatocyte co-culture with GPIbα-coupled beads, IL4R/GPIbα-transgenic mice, blocking antibodies\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple complementary genetic models (KO mice, transgenic, human BSS), in vitro reconstitution with GPIbα-beads, and rescue experiments establish mechanism\",\n      \"pmids\": [\"29794068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GPIbα is essential for membrane development in maturing megakaryocytes; its absence leads to poorly developed demarcation membrane system, reduced internal membrane pool, abnormal proplatelet production, and ultimately macrothrombocytopenia. Rescue with human GPIbα transgene corrects all ultrastructural defects.\",\n      \"method\": \"Electron microscopy, immunogold labeling, computer-based membrane quantification in GPIbα-null and GPIbα-null/hTg rescue mice\",\n      \"journal\": \"Experimental Hematology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ultrastructural analysis with quantification in genetic KO and transgenic rescue model\",\n      \"pmids\": [\"11937271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The GPIbα–filamin A interaction is required for demarcation membrane system (DMS) formation, correct subcellular distribution of filamin within megakaryocytes, and directional release of platelet buds into sinusoids; disrupting this interaction causes misdirected bud release into bone marrow interstitium and macrothrombocytopenia.\",\n      \"method\": \"Transgenic mouse model expressing filamin-binding-defective hGPIbα(FW), electron microscopy, intravital imaging of megakaryocytes\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — targeted mutagenesis in transgenic model with ultrastructural and functional characterization of DMS and bud release directionality\",\n      \"pmids\": [\"37922495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The last 24 residues of the GPIbα intracellular tail (harboring 14-3-3 and PI3K binding sites) are required for VWF-dependent signaling (filopodia formation) and GPVI-mediated signaling (P-selectin exposure, αIIbβ3 activation, pSyk); deletion of this domain reduces platelet spreading on CRP and reduces platelet aggregate formation on collagen under shear, without affecting ligand binding or ADP/thrombin responses.\",\n      \"method\": \"CRISPR-Cas9 GPIbαΔsig/Δsig transgenic mouse, flow assays, immunoblotting (pSyk), platelet spreading and aggregation assays\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR-generated mouse model with multiple orthogonal functional assays establishing distinct signaling roles for the intracellular tail\",\n      \"pmids\": [\"34134470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Thrombin binding to GPIbα (blocked by anti-GPIbα antibody VM16d or GPIbα cleavage by Mocarhagin) induces platelet aggregation via a signaling cascade independent of PAR-1 and PAR-4; this cascade activates Rho kinase p160ROCK (shape change), causes MEK-1 phosphorylation, and promotes fibrin binding to resting αIIbβ3, leading to fibrin-dependent platelet aggregation and clot retraction.\",\n      \"method\": \"PAR-desensitized platelets, function-blocking antibody, GPIbα-cleaving protease (Mocarhagin), signaling inhibitors, aggregometry\",\n      \"journal\": \"Thrombosis and Haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, multiple inhibitor tools but no genetic confirmation; mechanistic pathway defined pharmacologically\",\n      \"pmids\": [\"12719784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"GPIbα-selective activation (by multivalent VWF-A1/R543W-expressing COS-7 cells) triggers platelet aggregation through a signaling pathway dependent on Src, PI3K, and Syk, producing tyrosine phosphorylation patterns comparable to GPVI/collagen stimulation, establishing GPIbα as both an adhesion and signaling receptor.\",\n      \"method\": \"GPIbα-selective COS-7 cell agonist, kinase inhibitors, aggregometry, phosphorylation analysis with anti-Syk antibodies\",\n      \"journal\": \"Platelets\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, pharmacological dissection with selective agonist; Syk role later contested by separate study (PMID:28598382)\",\n      \"pmids\": [\"20367574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Syk kinase activity is dispensable for VWF/GP1b-induced platelet adhesion, agglutination, aggregation, and secretion; selective Syk inhibitors (OXSI-2, PRT-060318) block GPVI- but not GP1b-mediated platelet activation and signaling.\",\n      \"method\": \"Selective Syk inhibitors, VWF-induced aggregation/adhesion assays, comparison with GPVI agonist CRP in human and mouse platelets\",\n      \"journal\": \"International Journal of Molecular Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, pharmacological approach; negative result mechanistically informative and contradicts prior reports from PMID:20367574\",\n      \"pmids\": [\"28598382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GPIbα and PAR4 cooperate to generate thrombin-induced reactive oxygen species (ROS) in platelets via focal adhesion kinase (FAK) and NADPH oxidase 1 (NOX1); removal of the GPIbα ligand-binding region completely inhibits thrombin-induced ROS, and PAR4 deficiency abolishes it in mice.\",\n      \"method\": \"GPIbα-cleaving Naja kaouthia protease, PAR1/PAR4 antagonists, PAR4-deficient mice, flow cytometry ROS assay\",\n      \"journal\": \"Redox Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic tools (PAR4-KO mouse, GPIbα cleavage), two orthogonal inhibitor approaches identifying FAK/NOX1 pathway\",\n      \"pmids\": [\"26569550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"VWF self-associates on platelet GPIbα under hydrodynamic shear (>60–70 dyne/cm²), increasing effective VWF size and enhancing mechanotransduction and platelet activation through increased drag force on the receptor.\",\n      \"method\": \"Fluorescence-labeled VWF binding assays under shear, recombinant VWF lacking A1-domain (ΔA1-488), shear stress apparatus, whole blood flow assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, multiple biophysical tools but mechanistic model inferred from binding measurements without direct structural validation\",\n      \"pmids\": [\"20696943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The thermodynamic mechanism of VWF A1–GPIbα binding involves catch-to-slip bond behavior coupled to A1 domain conformational unfolding; A1 binds GPIbα with ~20-fold higher affinity in an intermediate (partially unfolded) conformation, and force-induced dissociation shifts equilibrium toward this high-affinity state.\",\n      \"method\": \"Circular dichroism, thermodynamic binding analysis, allosteric binding model, reduction/carboxyamidation of A1 disulfide\",\n      \"journal\": \"Biophysical Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with thermodynamic modeling, single lab, provides quantitative mechanistic framework\",\n      \"pmids\": [\"20713003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Type 2B VWD mutations (R1306Q, I1309V) destabilize the A1 domain structure and lower the force threshold for catch-to-slip bond transition with GPIbα, while a type 2M mutation (G1324S) stabilizes A1 and raises this threshold; A1 conformational stability is allosterically coupled to force-dependent GPIbα binding kinetics.\",\n      \"method\": \"Protein unfolding thermodynamics, atomic force microscopy (single-bond dissociation kinetics), site-specific VWF mutations\",\n      \"journal\": \"Biophysical Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with AFM force measurements and thermodynamic analysis of multiple disease-relevant mutations in a single study\",\n      \"pmids\": [\"19619477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GPIbα interacts with the FcγRIIA receptor via residues R542G543R544 on GPIbα and D298D299D300 on FcγRIIA, suggesting that GPIb-IX-V signaling leading to platelet activation may be partially mediated through FcγRIIA.\",\n      \"method\": \"Yeast two-hybrid system, mutagenesis\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — yeast two-hybrid with mutagenesis in a heterologous system, not validated in platelets; single lab, single method\",\n      \"pmids\": [\"10581159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"S100A8/A9 (calprotectin) induces formation of procoagulant (phosphatidylserine-positive) platelets by binding GPIbα; this was demonstrated using recombinant GPIbα ectodomain blockade, Bernard-Soulier syndrome platelets (GPIb-IX-V deficient), and mice lacking the extracellular domain of GPIbα, with a supporting role for CD36.\",\n      \"method\": \"Recombinant GPIbα ectodomain blockade, BSS patient platelets, GPIbα extracellular domain-deficient mice, flow cytometry, perfusion assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — three independent genetic/biological systems (BSS platelets, mouse KO, recombinant domain blockade) all confirm GPIbα as the S100A8/A9 receptor\",\n      \"pmids\": [\"36026606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Platelet-derived extracellular vesicles transfer GPIbα to blood monocytes via P-selectin-dependent adhesion stabilized by phosphatidylserine binding; GPIbα-positive monocytes then tether and roll on immobilized VWF or adhere to TGF-β1-treated endothelium in a GPIbα-dependent manner, providing an alternative thrombo-inflammatory leukocyte recruitment pathway.\",\n      \"method\": \"Flow cytometry, intravital microscopy (cremaster, carotid), in vitro rolling assays, function-blocking anti-GPIbα antibody, mouse in vivo models\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antibody blockade, in vitro and in vivo experiments, multiple disease models (diesel nanoparticles, ApoE atherosclerosis, trauma) all consistent\",\n      \"pmids\": [\"31467123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GPIbα-derived soluble protein produced by T cells acts through Mac-1 integrin on monocytes to stimulate PGE2, IL-1β, and IL-6 production in MDP-activated monocytes; anti-GPIbα or anti-Mac-1 antibody blockade inhibits this cytokine production, and recombinant GPIbα protein increases PGE2 production.\",\n      \"method\": \"Mass spectrometry identification, antibody blockade, recombinant GPIbα addition, Mac-1 KO mice in vivo, conditioned medium experiments\",\n      \"journal\": \"Science Signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS identification plus antibody blockade plus KO mice and recombinant protein, but novel/unexpected source of soluble GPIbα (T cells) warrants independent replication\",\n      \"pmids\": [\"31594856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Specific inhibition of GPIbα shedding (using monoclonal antibody 5G6 Fab) during platelet storage preserves GPIbα surface levels and significantly improves post-transfusion platelet recovery and hemostatic function without altering platelet activation, degranulation, or aggregation, demonstrating that GPIbα shedding is a causal mechanism of storage-induced platelet clearance.\",\n      \"method\": \"Monoclonal antibody Fab fragment (5G6) specific for GPIbα shedding inhibition, room-temperature platelet storage, transfusion into mice, ex vivo thrombus formation under shear flow\",\n      \"journal\": \"Arteriosclerosis, Thrombosis, and Vascular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — specific pharmacological inhibitor, human and transgenic mouse platelets, in vivo transfusion recovery and functional assays\",\n      \"pmids\": [\"27417583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADAM17 and its GPIbα substrate are both stored intracellularly in platelets, not on the surface; ADAM17 localizes to a distinct intracellular membrane system separate from α- and dense granules. Only a GPIbα subpopulation that becomes accessible after strong stimulation serves as ADAM17 substrate, and shedding occurs with kinetics (20 min–3 h) suggesting a role beyond hemostasis. Membrane-permeable ADAM17 inhibitors (but not proteinaceous inhibitors) can block shedding.\",\n      \"method\": \"Transmission electron microscopy with immunogold staining, immunoprecipitation, quantitative western blotting, selective inhibitors\",\n      \"journal\": \"Journal of Thrombosis and Haemostasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct ultrastructural localization with immunogold EM combined with biochemical studies defining two GPIbα subpopulations and spatial control of ADAM17 activity\",\n      \"pmids\": [\"37001816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CLEC-2 deletion in platelets inhibits αIIbβ3 activation induced by VWF binding to GPIbα without preventing VWF binding itself, demonstrating that CLEC-2 acts downstream of GPIbα to mediate integrin activation and platelet aggregation in TTP-like conditions.\",\n      \"method\": \"Platelet-specific CLEC-2 knockout mice, VWF-binding assays, αIIbβ3 activation assays, mouse TTP model (anti-ADAMTS13 antibody + VWF infusion)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO model with clearly separated binding vs. signaling steps, in vivo TTP model validates pathophysiological relevance\",\n      \"pmids\": [\"35157766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A cell-penetrating peptide corresponding to GPIbα cytoplasmic residues 557–569 reduces VWF-dependent platelet adhesion and profoundly inhibits filopodia formation on VWF matrix, and abolishes shape change in CHO-GPIb-IX cells, demonstrating a functional role of this domain in VWF-dependent adhesion signaling.\",\n      \"method\": \"Cell-penetrating peptide (R9-coupled), platelet adhesion on VWF matrix, CHO-GPIb-IX cell adhesion assays, aggregometry\",\n      \"journal\": \"Journal of Thrombosis and Haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, peptide-based approach without genetic confirmation; validated in both platelets and heterologous cells\",\n      \"pmids\": [\"17100656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The GPIbα Gly233Val gain-of-function mutation (platelet-type VWD) enhances formation and increases longevity of the GPIbα–VWF-A1 tether bond (k⁰off mutant 0.67 s⁻¹ vs. native 3.45 s⁻¹) without altering bond strength under applied force, promoting platelet adhesion at shear rates that do not support wild-type binding.\",\n      \"method\": \"Single-molecule kinetics of tether bond formation and dissociation using PT-VWD platelets, flow chamber assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous biophysical single-molecule assay with quantitative kinetics, single lab, human disease mutation\",\n      \"pmids\": [\"12637314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The HPA-2 (Ko) alloantigens are located on GPIbα; the HPA-2b (Koa) allele encodes Met145 and HPA-2a (Kob) encodes Thr145, resulting from a C-T polymorphism at position 434 of the coding region. Anti-HPA-2a antibodies inhibit ristocetin-induced agglutination of HPA-2a-positive platelets, placing the epitope near the VWF-binding domain.\",\n      \"method\": \"PCR amplification and DNA sequencing, restriction fragment length polymorphism (RFLP), platelet agglutination inhibition assay\",\n      \"journal\": \"Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct sequencing of multiple donors, functional agglutination inhibition assay, and RFLP validation all consistent; foundational identification of the polymorphism\",\n      \"pmids\": [\"1346615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The HPA-2 Thr145Met polymorphism affects VWF binding (HPA-2a/Thr145 binds VWF with higher affinity) but does not affect α-thrombin binding to GPIbα, indicating that the dimorphism modulates the conformation of the N-terminal flanking region and first leucine-rich repeat.\",\n      \"method\": \"Recombinant GPIbα N-terminal fragments (AA1-289) from CHO cells, resonant mirror binding studies, monoclonal antibody epitope mapping\",\n      \"journal\": \"Arteriosclerosis, Thrombosis, and Vascular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — recombinant protein binding assays and HPA-2 homozygous platelets, two methods, single lab\",\n      \"pmids\": [\"12775575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Prolonged inhibition of protein kinase A (PKA) results in metalloproteinase-dependent GPIbα shedding from platelets; this is reversed by PKA activator forskolin, partially inhibited by calpain inhibitors, and completely blocked by metalloproteinase inhibitor GM6001, indicating PKA activity normally restrains ADAM17-mediated GPIbα cleavage.\",\n      \"method\": \"PKA inhibitor H89, PKA activator (forskolin), GM6001, calpain inhibitors, flow cytometry, VWF-dependent adhesion assays\",\n      \"journal\": \"Thrombosis Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, pharmacological approach without genetic confirmation; multiple inhibitor tools used consistently\",\n      \"pmids\": [\"19181367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Mitochondrial permeability transition pore (MPTP) opening triggers mitochondrial ROS production that promotes ADAM17-mediated GPIbα ectodomain shedding; mitochondrial Ca²⁺ uptake via MCU triggers MPTP opening, and both ROS and calpain contribute to shedding downstream of MPTP.\",\n      \"method\": \"MPTP inhibitor/potentiator, mitochondrial Ca²⁺ measurements, MCU inhibitor Ru360, BAPTA-AM, mitochondria-targeted ROS scavenger, calpain inhibitors, flow cytometry\",\n      \"journal\": \"Platelets\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, multiple pharmacological tools delineating pathway, but no genetic confirmation of individual steps\",\n      \"pmids\": [\"23909816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Integrity of the leucine-rich repeat region of GPIbα is essential for normal glycosylation and surface expression of the GPIb-IX complex; the Nancy I mutation (deletion of Leu179) causes a 40% reduction in GPIbα molecular weight due to glycosylation deficiency, reduced surface expression, and complete loss of VWF binding and rolling on VWF surfaces.\",\n      \"method\": \"CHO cell transfection with wild-type and mutant GPIbα, flow cytometry, biochemical glycosylation analysis, static adhesion and perfusion assays on VWF\",\n      \"journal\": \"Thrombosis and Haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — heterologous expression with biochemical and functional readouts; natural disease mutation validates clinical relevance\",\n      \"pmids\": [\"10928479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The O-glycosylated N-linker of VWF A1 reduces GPIbα binding affinity ~40-fold primarily through its O-glycan moiety and increases A1 thermal stability by raising the energy gap between native and intermediate states; the C-linker also decreases A1 affinity for GPIbα but has no effect on A1 stability or hydrogen-deuterium exchange, indicating distinct allosteric mechanisms for the two linkers.\",\n      \"method\": \"Binding affinity/kinetics measurements, thermodynamics, hydrogen-deuterium exchange (HDX), urea/temperature-induced unfolding, recombinant VWF A1 constructs\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods (HDX, thermodynamics, kinetics, stability), rigorous dissection of polypeptide vs. glycan contributions\",\n      \"pmids\": [\"35532124\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GPIbα is the ligand-binding subunit of the platelet GPIb-IX-V complex that initiates hemostasis and thrombosis by binding VWF at sites of vascular injury via a catch-slip bond mechanism regulated by A1 domain conformation, interacts with thrombin exclusively at exosite II to recruit protease activity to the platelet surface, signals through its intracellular tail (via 14-3-3ζ, PI3K, and FAK/NOX1) to activate integrin αIIbβ3 and generate ROS in cooperation with PAR4 and CLEC-2, anchors the membrane skeleton through filamin A to maintain mechanical stability under shear and control megakaryocyte demarcation membrane system formation and platelet size, undergoes ADAM17-mediated ectodomain shedding from an intracellular GPIbα subpopulation triggered by strong stimulation (regulated by PKA, ROS, and MPTP), serves as the receptor for S100A8/A9 and fucoidan to induce procoagulant platelet formation, and mediates platelet-to-monocyte GPIbα transfer via extracellular vesicles to enable VWF-dependent inflammatory leukocyte recruitment, while also being required for platelet-mediated hepatic thrombopoietin generation through a direct hepatocyte interaction involving its N-terminal extracellular domain.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GPIbα is the ligand-binding subunit of the platelet GPIb-IX-V complex that initiates hemostasis and thrombosis by capturing von Willebrand factor (VWF) and recruiting thrombin to the platelet surface [#4, #1]. Its extracellular domain engages thrombin exclusively at anion-binding exosite II through residues D274–E285, leaving exosite I free for PAR-1 recognition [#1, #2], and the same complex can simultaneously bridge two thrombin molecules to scaffold adhesion [#0]. Binding to VWF is governed by force-dependent catch-to-slip bond behavior coupled to A1-domain conformational unfolding, with A1 stability allosterically tuning the force threshold for engagement—a mechanism that disease-associated VWF and GPIbα mutations shift toward higher or lower affinity [#19, #20, #29]. Engagement of GPIbα is essential and VWF-independent for platelet recruitment to subendothelium and growing thrombi under arterial flow [#4]. Beyond adhesion, GPIbα is a signaling receptor: its intracellular tail binds 14-3-3ζ and PI3K to drive filopodia formation, αIIbβ3 activation, and platelet spreading, with these signals cooperating with GPVI, PAR4, and CLEC-2 downstream pathways including FAK/NOX1-dependent ROS generation [#5, #13, #17, #27]. The GPIbα cytoplasmic tail also anchors the membrane skeleton via filamin A, a coordinated interaction required for mechanical stability under shear, megakaryocyte demarcation membrane system formation, directional platelet release, and normal platelet size [#6, #7, #11, #12]; loss of GPIbα or its filamin link produces macrothrombocytopenia. GPIbα surface levels are controlled by ADAM17-mediated ectodomain shedding from an intracellular GPIbα subpopulation, a process restrained by PKA and triggered by desialylation, ROS, and mitochondrial permeability transition, and shedding is a causal driver of storage- and refrigeration-induced platelet clearance [#3, #8, #26, #32, #33, #25]. GPIbα additionally serves as the receptor for S100A8/A9 to generate procoagulant platelets [#22], engages leukocyte Mac-1 to promote thrombosis and modulate monocyte transcription [#9], can be transferred to monocytes via extracellular vesicles to enable VWF-dependent leukocyte recruitment [#23], and is required for platelet-mediated hepatic thrombopoietin generation through a direct hepatocyte interaction of its N-terminal domain [#10]. Loss-of-function in GPIbα underlies Bernard-Soulier syndrome, manifesting as reduced circulating TPO and macrothrombocytopenia [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing that the HPA-2 alloantigen system maps to a Thr145Met polymorphism on GPIbα localized the immunologically and clinically relevant epitope to the VWF-binding region.\",\n      \"evidence\": \"DNA sequencing, RFLP, and agglutination inhibition assay across donors\",\n      \"pmids\": [\"1346615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the functional consequence of the dimorphism for ligand binding\", \"No structural localization within the N-terminal domain\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Two studies defined the GPIbα cytoplasmic tail as a docking platform, showing residues 570–590 bind 14-3-3ζ under PKA regulation, answering how an adhesion receptor couples to intracellular signaling.\",\n      \"evidence\": \"Truncation mutagenesis, GST-pulldown, and co-IP in CHO cells and platelets; LRR-region glycosylation/expression analysis in CHO cells\",\n      \"pmids\": [\"10627461\", \"10928479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling consequences of 14-3-3ζ binding not resolved\", \"Did not define how shear-induced dissociation is sensed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that GPIbα-null megakaryocytes have defective demarcation membrane systems established a developmental role for GPIbα in platelet biogenesis beyond hemostasis.\",\n      \"evidence\": \"Electron microscopy and immunogold quantification in GPIbα-null and human GPIbα transgenic rescue mice\",\n      \"pmids\": [\"11937271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the molecular effector linking GPIbα to membrane development\", \"Mechanistic link to filamin not yet established at this stage\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Structural and single-molecule work defined how GPIbα engages thrombin and how a gain-of-function mutation tunes the VWF tether bond, clarifying both the thrombin-recruitment scaffold and the kinetic basis of shear-dependent adhesion.\",\n      \"evidence\": \"X-ray crystallography of GPIbα–thrombin; single-molecule tether-bond kinetics of PT-VWD platelets; PAR-desensitized platelet signaling with blocking antibody and Mocarhagin\",\n      \"pmids\": [\"12855811\", \"12637314\", \"12719784\", \"12775575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystallographic dual-thrombin stoichiometry later refined to exosite-II-only binding\", \"PAR-independent aggregation pathway defined only pharmacologically without genetic confirmation\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying ADAM17 as the metalloproteinase that sheds the GPIbα ectodomain established the enzymatic basis for surface receptor downregulation and platelet clearance.\",\n      \"evidence\": \"TACE-inactive chimeric mice, TACE inhibitors, and in vivo/in vitro shedding assays\",\n      \"pmids\": [\"15345652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the physiological trigger or subcellular site of shedding\", \"Upstream regulation of ADAM17 unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Replacing the GPIbα ectodomain in vivo showed it is absolutely and VWF-independently required for platelet recruitment under arterial flow, establishing GPIbα as the indispensable adhesion initiator; a tail-derived peptide implicated cytoplasmic residues 557–569 in adhesion signaling.\",\n      \"evidence\": \"IL4Rα/GPIbα transgenic mice with intravital microscopy and adoptive transfer; cell-penetrating GPIbα(557–569) peptide in platelet and CHO adhesion assays\",\n      \"pmids\": [\"17075060\", \"17100656\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Peptide approach lacked genetic confirmation\", \"Nature of the VWF-independent adhesion ligand not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Biophysical mapping placed the thrombin interface at GPIbα residues D274–E285 on exosite II and showed PKA inhibition drives metalloproteinase-dependent shedding, beginning to delineate both the thrombin-binding chemistry and shedding regulation.\",\n      \"evidence\": \"NMR/AUC/HDX-MS of the thrombin interface; AFM and unfolding thermodynamics of VWD A1 mutants; PKA inhibitor/forskolin shedding assays\",\n      \"pmids\": [\"19591434\", \"19619477\", \"19181367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PKA-shedding link defined pharmacologically without genetic confirmation\", \"Mechanism connecting PKA to ADAM17 activity unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A cluster of studies established the GPIbα–filamin A interaction as the membrane-skeleton anchor required for shear resistance, and defined the catch-slip thermodynamics and VWF self-association that govern force-dependent adhesion and mechanotransduction.\",\n      \"evidence\": \"Filamin-binding-defective hGPIbα(FW) transgenic mice under high shear; CD/thermodynamic A1 binding analysis; GPIbα-selective COS-7 agonist with kinase inhibitors; shear VWF self-association binding assays\",\n      \"pmids\": [\"21156842\", \"20713003\", \"20367574\", \"20696943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Syk dependence of GPIbα signaling later contested\", \"Self-association model inferred from binding without structural validation\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linking GPIbα expression to filamin A trafficking and platelet size, and showing desialylation routes GPIbα to ADAM17 shedding and clearance, connected receptor biogenesis and turnover to platelet homeostasis.\",\n      \"evidence\": \"ESC-derived platelets and HEK293T trafficking assays; sialidase inhibitors with Adam17-null platelets and in vivo clearance assays\",\n      \"pmids\": [\"22174152\", \"22101895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking mechanism coordinating GPIbα and filamin not molecularly resolved\", \"How desialylation exposes the cleavage site unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Refining the thrombin interface to exosite-II-only binding and identifying MPTP-driven mitochondrial ROS as a shedding trigger sharpened both the thrombin-recruitment model and the upstream control of GPIbα cleavage.\",\n      \"evidence\": \"Mutagenesis, crystallography, and NMR of thrombin binding; MPTP/MCU pharmacology and mitochondrial ROS measurements for shedding\",\n      \"pmids\": [\"24316004\", \"23909816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MPTP-shedding pathway defined pharmacologically without genetic confirmation of individual steps\", \"Physiological context triggering MPTP-dependent shedding unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that GPIbα cooperates with PAR4 via FAK and NOX1 to generate thrombin-induced ROS placed GPIbα within a redox signaling node downstream of platelet activation.\",\n      \"evidence\": \"GPIbα-cleaving protease, PAR antagonists, PAR4-deficient mice, and flow cytometric ROS assays\",\n      \"pmids\": [\"26569550\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical coupling between GPIbα and the FAK/NOX1 module not shown\", \"Pharmacological dissection without GPIbα genetic confirmation\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two studies extended GPIbα biology to leukocyte engagement via Mac-1 and resolved the contested role of Syk, showing Syk activity is dispensable for VWF/GPIbα-induced platelet responses.\",\n      \"evidence\": \"Mac-1 knockout and binding-site mutant mice with adoptive transfer and injury models; selective Syk inhibitors comparing GPIbα versus GPVI signaling\",\n      \"pmids\": [\"28555620\", \"28598382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Syk negative result derived from a single pharmacological study\", \"Molecular consequences of Mac-1–GPIbα binding for monocyte Foxp1 not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Establishing that the GPIbα N-terminal domain is required for platelet-driven hepatic thrombopoietin generation revealed a homeostatic feedback role linking platelet receptor to TPO production.\",\n      \"evidence\": \"GPIbα-null and IL4R/GPIbα transgenic mice, BSS patient samples, transfusion rescue, and hepatocyte co-culture with GPIbα-coupled beads\",\n      \"pmids\": [\"29794068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hepatocyte receptor/partner for GPIbα not identified\", \"Signaling pathway driving hepatic TPO transcription unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that GPIbα can be transferred to monocytes via extracellular vesicles, and that a soluble T-cell-derived GPIbα acts through Mac-1, expanded GPIbα function into thrombo-inflammatory leukocyte recruitment and cytokine signaling.\",\n      \"evidence\": \"Flow cytometry, intravital and in vitro rolling assays with anti-GPIbα blockade; MS identification, recombinant GPIbα, antibody blockade, and Mac-1 KO mice\",\n      \"pmids\": [\"31467123\", \"31594856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"T-cell as a source of soluble GPIbα warrants independent replication\", \"Receptor mechanism on hepatocytes/leukocytes incompletely defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A set of studies established CLEC-2 as a downstream effector of GPIbα-driven integrin activation, identified GPIbα as the S100A8/A9 receptor for procoagulant platelet formation, and dissected how VWF A1 linkers allosterically tune GPIbα affinity.\",\n      \"evidence\": \"Platelet-specific CLEC-2 KO mice with TTP model; GPIbα ectodomain blockade, BSS platelets, and GPIbα-deficient mice; HDX and thermodynamic analysis of A1 linker constructs\",\n      \"pmids\": [\"35157766\", \"36026606\", \"35532124\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physical coupling between GPIbα and CLEC-2 not defined\", \"Mechanism translating S100A8/A9 binding into phosphatidylserine exposure unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that ADAM17 and a GPIbα substrate subpopulation are stored intracellularly redefined shedding as a spatially controlled event requiring strong stimulation rather than constitutive surface cleavage.\",\n      \"evidence\": \"Immunogold transmission EM, immunoprecipitation, quantitative western blotting, and membrane-permeable versus proteinaceous ADAM17 inhibitors\",\n      \"pmids\": [\"37001816\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking route exposing the intracellular GPIbα subpopulation unclear\", \"The non-hemostatic function implied by slow shedding kinetics not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing the GPIbα–filamin A interaction directs demarcation membrane formation and the directional release of platelet buds into sinusoids linked the membrane-skeleton anchor to spatially controlled thrombopoiesis.\",\n      \"evidence\": \"Filamin-binding-defective hGPIbα(FW) transgenic mice with electron microscopy and intravital megakaryocyte imaging\",\n      \"pmids\": [\"37922495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular cue establishing release directionality not identified\", \"How filamin redistribution is regulated by the GPIbα link unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the hepatocyte receptor mediating GPIbα-dependent thrombopoietin generation and the molecular pathway coupling GPIbα adhesion signaling to its multiple cooperating receptors (CLEC-2, PAR4, FAK/NOX1) remain to be defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No identified hepatocyte partner for GPIbα N-terminal domain\", \"Physical basis of GPIbα–CLEC-2 functional coupling unknown\", \"Mechanism integrating GPIbα signaling with redox and procoagulant outputs incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [4, 19, 29]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [13, 15, 17, 27]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [6, 7, 12]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 6, 26]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [6, 7, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [4, 0, 1]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 13, 17]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 23, 24]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [11, 12]}\n    ],\n    \"complexes\": [\"GPIb-IX-V complex\"],\n    \"partners\": [\"VWF\", \"thrombin\", \"filamin A\", \"14-3-3ζ\", \"PI3K\", \"Mac-1\", \"S100A8/A9\", \"CLEC-2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}